BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6258910)

  • 41. The glycogenic effects of placental lactogen and growth hormone in ovine fetal liver are mediated through binding to specific fetal ovine placental lactogen receptors.
    Freemark M; Handwerger S
    Endocrinology; 1986 Feb; 118(2):613-8. PubMed ID: 3002758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver.
    McCarter J; Shaw MA; Winer LA; Baumann G
    Mol Cell Endocrinol; 1990 Oct; 73(1):11-4. PubMed ID: 2292336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of lysine residues in the binding of ovine chorionic somatomammotropin to lactogenic and somatotropic receptors.
    Chêne N; Martal J; de la Llosa P
    FEBS Lett; 1984 Jan; 166(2):352-6. PubMed ID: 6319197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatogenic and lactogenic activity of the recombinant 22 kDa isoform of human placental growth hormone.
    Igout A; Frankenne F; L'Hermite-Balériaux M; Martin A; Hennen G
    Growth Regul; 1995 Mar; 5(1):60-5. PubMed ID: 7749349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancement of rat growth hormone binding by membrane disulfide reduction.
    Kover K; Hung CH; Moore WV
    Endocrinology; 1985 Mar; 116(3):1017-23. PubMed ID: 2982566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
    Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
    Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of human growth hormone (GH)-variant (placental GH) to GH-binding proteins in human plasma.
    Baumann G; Dávila N; Shaw MA; Ray J; Liebhaber SA; Cooke NE
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1175-9. PubMed ID: 1955498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific binding of iodinated growth hormone to rat liver in vivo.
    Turyn D; Dellacha JM
    Endocrinology; 1978 Oct; 103(4):1190-5. PubMed ID: 217670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allosteric effects of monoclonal antibodies on human growth hormone.
    Aguilar RC; Retegui LA; Postel-Vinay MC; Roguin LP
    Mol Cell Biochem; 1994 Jul; 136(1):35-42. PubMed ID: 7531816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovine placental lactogen and human growth hormone bind to different regions of the same receptors.
    Longhi SA; Wolfenstein-Todel C; Gómez KA; Miranda ME; Retegui LA
    Growth Horm IGF Res; 1999 Jun; 9(3):157-64. PubMed ID: 10502451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human growth hormone-variant is a biologically active somatogen and lactogen.
    MacLeod JN; Worsley I; Ray J; Friesen HG; Liebhaber SA; Cooke NE
    Endocrinology; 1991 Mar; 128(3):1298-302. PubMed ID: 1999151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary and recombinant deoxyribonucleic acid-derived human growth hormones alter glucose metabolism in 3T3 adipocytes.
    Schwartz J; Foster CM
    J Clin Endocrinol Metab; 1986 Apr; 62(4):791-4. PubMed ID: 3005358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [22K and 20K growth hormone: correlation of receptor binding and the biological effect on rat adipocytes].
    Smal J; Closset J; Hennen G; De Meyts P
    Reprod Nutr Dev (1980); 1987; 27(2B):521-2. PubMed ID: 3306847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone binding to specific receptors stimulates growth and function of cloned insulin-producing rat insulinoma RIN-5AH cells.
    Billestrup N; Martin JM
    Endocrinology; 1985 Mar; 116(3):1175-81. PubMed ID: 2982576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth hormone maintains its own receptors in rat adipocytes.
    Grichting G; Goodman HM
    Endocrinology; 1986 Aug; 119(2):847-54. PubMed ID: 3015559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of growth hormone to rat liver during experimental chemical hepatocarcinogenesis.
    Roitman A; Lev-Ran A; Carr BI; Hwang DL; Barseghian G
    Endocrinology; 1986 May; 118(5):1869-71. PubMed ID: 3009139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemical modification of human growth hormone with N-acetylimidazole. Effect on binding capacity to lactogenic and somatogenic receptors.
    Kaliman P; Ermácora MR; Nowicki C; Wolfenstein-Todel C; Santomé JA
    Int J Pept Protein Res; 1991 Jul; 38(1):38-46. PubMed ID: 1657805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localization and specificity of binding of subprimate placental lactogen in rabbit tissues.
    Bolander FF; Hurley TW; Handwerger S; Fellows RE
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2932-5. PubMed ID: 183216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of hepatic growth hormone binding sites of pregnant rabbit crosslinked to 125I-labelled human growth hormone.
    Tsushima T; Murakami H; Wakai K; Isozaki O; Sato Y; Shizume K
    FEBS Lett; 1982 Oct; 147(1):49-53. PubMed ID: 6291998
    [No Abstract]   [Full Text] [Related]  

  • 60. Specific binding of growth hormone to isolated chondrocytes from rabbit ear and epiphyseal plate.
    Eden S; Isaksson OG; Madsen K; Friberg U
    Endocrinology; 1983 Mar; 112(3):1127-9. PubMed ID: 6295745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.